HeartBeam Insider Robert Paul Eno Files Form 4 for Ownership Change

TL;DR

**HeartBeam insider Robert Paul Eno filed a Form 4, signaling a change in his ownership.**

AI Summary

This Form 4 filing indicates that Robert Paul Eno, a reporting insider, had a change in beneficial ownership of securities in HeartBeam, Inc. (Issuer CIK: 0001779372) as of February 9, 2026. While the specific transaction details aren't in this summary, the filing itself confirms his ongoing reporting obligations for the company, which is incorporated in Delaware and operates in Surgical & Medical Instruments & Apparatus. This matters to investors because insider activity can signal confidence or concern about the company's future, and tracking these filings helps assess management's alignment with shareholder interests.

Why It Matters

Insider filings like this provide transparency into how key company figures are managing their stakes, which can influence investor perception and stock valuation.

Risk Assessment

Risk Level: low — This filing is purely administrative, reporting a change in beneficial ownership, and does not inherently indicate a high risk.

Analyst Insight

A smart investor would monitor subsequent filings to see the specific nature of the transaction (buy or sell) and its size, as this initial filing only indicates a change occurred.

Key Players & Entities

• ENO Robert Paul (person) — Reporting insider for HeartBeam, Inc.
• HeartBeam, Inc. (company) — The issuer of the securities
• 0001963418 (person) — CIK for ENO Robert Paul
• 0001779372 (company) — CIK for HeartBeam, Inc.
• 2026-02-09 (date) — Period of Report

FAQ

Filing Documents

• ownership.html (4)
• ownership.xml (4) — 4KB
• 0001213900-26-033021.txt ( ) — 6KB

From the Filing

SEC FORM 4 SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. 1. Name and Address of Reporting Person * ENO Robert Paul (Last) (First) (Middle) 2118 WALSH AVE, SUITE 210 (Street) SANTA CLARA CALIFORNIA 95050 (City) (State) (Zip) UNITED STATES (Country) 2. Issuer Name and Ticker or Trading Symbol HeartBeam, Inc. [ BEAT ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) President 2a. Foreign Trading Symbol 3. Date of Earliest Transaction (Month/Day/Year) 02/09/2026 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person 4. If Amendment, Date of Original Filed (Month/Day/Year) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Common Stock (right to buy) $ 1.45 02/09/2026 A 55,172 (1) 01/01/2036 Common Stock 55,172 $ 0 55,172 D Explanation of Responses: 1. Granted options on February 9, 2026 (the "Special Option"), one half of the total number of shares of common stock (the "Shares") subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan. /s/ Robert Paul Eno 03/23/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. * Form 4: SEC 1474 (03-26)

View Full Filing

View this 4 filing on SEC EDGAR